These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 353073)

  • 1. Biotyping of Serratia marcescens and its use in epidemiological studies.
    Grimont PA; Grimont F
    J Clin Microbiol; 1978 Jul; 8(1):73-83. PubMed ID: 353073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of Grimont biotyping system for epidemiologic studies with nosocomial Serratia marcescens isolates.
    Sifuentes-Osornio J; Gröschel DH
    J Clin Microbiol; 1987 Mar; 25(3):567-8. PubMed ID: 3553228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system.
    Sifuentes-Osornio J; Ruiz-Palacios GM; Gröschel DH
    J Clin Microbiol; 1986 Feb; 23(2):230-4. PubMed ID: 3517048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined serotyping and biotyping of Serratia marcescens.
    Rubin SJ; Brock S; Chamberland M; Lyons RW
    J Clin Microbiol; 1976 Jun; 3(6):582-5. PubMed ID: 780372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a biotyping system and DNA restriction fragment analysis to the study of Serratia marcescens from hospitalized patients.
    Bale M; Sanford M; Hollis R; Pfaller MA
    Diagn Microbiol Infect Dis; 1993 Jan; 16(1):1-7. PubMed ID: 8381062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial Serratia marcescens individualized by five typing methods in a regional hospital.
    Larose P; Picard B; Thibault M; Grimont F; Goullet P
    J Hosp Infect; 1990 Feb; 15(2):167-72. PubMed ID: 1969439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serratia marcescens infections in a hospital: typing of isolated strains].
    Yde M
    Arch Belg; 1989; 47(5-6):189-210. PubMed ID: 2700064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotyping of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C; Cruz-Camarillo R
    Rev Latinoam Microbiol; 1992; 34(4):253-8. PubMed ID: 1345114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and bacteriological investigation of Serratia marcescens epidemic in a nursery and in a neonatal intensive care unit.
    Montanaro D; Grasso GM; Annino I; De Ruggiero N; Scarcella A; Schioppa F
    J Hyg (Lond); 1984 Aug; 93(1):67-78. PubMed ID: 6379044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative biotyping, bacteriocin typing, and serogrouping (O-antigens) of Serratia liquefaciens.
    Traub WH
    Zentralbl Bakteriol; 1991 Jun; 275(2):200-10. PubMed ID: 1718303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatible results obtained from biotyping and serotyping in Serratia marcescens.
    Grimont PA; Grimont F; Le Minor S; Davis B; Pigache F
    J Clin Microbiol; 1979 Oct; 10(4):425-32. PubMed ID: 393712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of biotyping and electrophoretic patterns of esterases for differentiation of nosocomial Serratia marcescens strains.
    Chetoui H; Delhalle E; Osterrieth P; Rousseaux D
    Res Microbiol; 1995 Sep; 146(7):579-86. PubMed ID: 8577999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme polymorphism, prodigiosin production, and plasmid fingerprints in clinical and naturally occurring isolates of Serratia marcescens.
    Gargallo-Viola D
    J Clin Microbiol; 1989 May; 27(5):860-8. PubMed ID: 2663918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of molecular typing to study the epidemiology of Serratia marcescens.
    McGeer A; Low DE; Penner J; Ng J; Goldman C; Simor AE
    J Clin Microbiol; 1990 Jan; 28(1):55-8. PubMed ID: 2405015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typing of nosocomial strains of Serratia marcescens: comparison of pulsed-field gel electrophoresis of macrorestriction fragments with biotyping, esterase typing and ribotyping.
    Chetoui H; Delhalle E; Melin P; Struelens MJ; De Ryck R; Osterrieth P; De Mol P
    Res Microbiol; 1998 Feb; 149(2):137-43. PubMed ID: 9766216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriocin typing and biotyping of clinical isolates of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):474-86. PubMed ID: 1755921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
    Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
    Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological evaluation of Serratia marcescens clinical isolates in a general hospital during the past three years: appearance of O-antigens O2 and O14].
    Marumo K; Nakamura Y; Sakurai C
    Rinsho Byori; 1998 Jul; 46(7):728-33. PubMed ID: 9721543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.